The significance of gene detection of thyroid nodule fine needle puncture tissue for the assessment of malignant degree and prognosis of differentiated thyroid carcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037824

Enrollment

Unknown

Registered

2020-09-02

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated thyroid carcinoma

Interventions

PTC with mutation:Nil

FTC with mutation:Nil

FTC without mutation:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) ultrasound examination was diagnosed as thyroid nodules, the indications of the thyroid nodules, and were prepared to receive patients with thyroid nodules, fnaand pathological examination. (2) the patient was aged 70 years old.

Exclusion criteria

Exclusion criteria: (1) Thyroid nodule US-FNAB contraindication: bleeding tendency, significantly prolonged emergence and coagulation time, and significantly decreased prothrombin activity; The puncture route may damage the adjacent vital organs;Long-term use of anticoagulants;Frequent coughing, swallowing and other difficulties to cooperate; Reject the invasive examiner; Puncture site infection should be treated before puncture. (2) patients with other malignant tumors or other diseases that may affect life expectancy; (3) Patients who refuse to undergo genetic testing.

Design outcomes

Primary

Measure	Time frame
pathological type;	—

Secondary

Measure	Time frame
tumor size;lymphatic metastasis;Local invasion;Distant metastasis;Recurrence;	—

Countries

China

Contacts

Public ContactYufang Liu

Peking University International Hospital

546295722@qq.com+86 15901020714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026